Domenica F. Mariniello

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Selective phosphodiesterase 4B inhibition in fibrotic lung disease: a scoping review of vascular-immune mechanisms and extrapulmonary implications.

Selective phosphodiesterase 4B inhibition in fibrotic lung disease: a scoping review of vascular-immune mechanisms and extrapulmonary implications.

Journal: European respiratory review : an official journal of the European Respiratory Society

Published: March 17, 2026

Role of Airwave Oscillometry in Patients with Combined Fibrosis-Emphysema Syndrome (CPFE) with Preserved FEV1/FVC Ratio.

Role of Airwave Oscillometry in Patients with Combined Fibrosis-Emphysema Syndrome (CPFE) with Preserved FEV1/FVC Ratio.

Journal: Diagnostics (Basel, Switzerland)

Published: March 03, 2026

Nerandomilast in Autoimmune-Associated Interstitial Lung Diseases: Translating Evidence from Progressive Pulmonary Fibrosis Studies.

Nerandomilast in Autoimmune-Associated Interstitial Lung Diseases: Translating Evidence from Progressive Pulmonary Fibrosis Studies.

Journal: Journal of clinical medicine

Published: February 17, 2026

The Efficacy of High-Flow Nasal Cannula (HFNC) Treatment in Patients with Chronic Type II Respiratory Failure Secondary to COPD.

The Efficacy of High-Flow Nasal Cannula (HFNC) Treatment in Patients with Chronic Type II Respiratory Failure Secondary to COPD.

Journal: Journal of clinical medicine

Published: January 18, 2026

Frailty and functional outcomes in patients with progressive fibrosing interstitial lung diseases receiving antifibrotic therapy: a real-life observational study.

Frailty and functional outcomes in patients with progressive fibrosing interstitial lung diseases receiving antifibrotic therapy: a real-life observational study.

Journal: Frontiers in medicine

Published: November 07, 2025

Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management.

Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management.

Journal: Biomedicines

Published: May 29, 2025

Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study.

Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study.

Journal: Pharmacy (Basel, Switzerland)

Published: January 29, 2025

Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents.

Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents.

Journal: Pharmaceutics

Published: September 06, 2024

Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease.

Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease.

Journal: Biomedicines

Published: April 17, 2024

Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis.

Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis.

Journal: Respiratory research

Published: March 08, 2024

Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders.

Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders.

Journal: Drugs

Published: March 07, 2024

Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist's Key Role.

Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist's Key Role.

Journal: International journal of molecular sciences

Published: February 01, 2024

Showing 1-12 of 27

Last Updated: 09/26/2026